Franklin Resources Inc Zymeworks Inc. Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.82 - $7.7 $2.89 Million - $4.62 Million	-600,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.0 - $16.98 $3.94 Million - $11.2 Million	-657,090 Reduced 52.27%	600,000 $3.93 Million
Q4 2021 Feb 11, 2022	BUY	$15.19 - $29.33 $850 - $1,642	56 Added 0.0%	1,257,090 $20.6 Million
Q3 2021 Nov 12, 2021	SELL	$27.35 - $37.28 $1,367 - $1,864	-50 Reduced -0.0%	1,257,034 $36.5 Million
Q2 2021 Aug 13, 2021	BUY	$26.5 - $38.23 $3.16 Million - $4.56 Million	119,200 Added 10.48%	1,257,084 $43.6 Million
Q4 2020 Feb 10, 2021	BUY	$39.12 - $54.99 $2,699 - $3,794	69 Added 0.01%	1,137,884 $53.8 Million
Q3 2020 Nov 12, 2020	BUY	$29.21 - $46.58 $6.5 Million - $10.4 Million	222,600 Added 24.32%	1,137,815 $53 Million
Q2 2020 Aug 13, 2020	BUY	$33.67 - $40.0 $14.3 Million - $16.9 Million	423,600 Added 86.16%	915,215 $29 Million
Q1 2020 May 13, 2020	SELL	$24.28 - $49.8 $2.31 Million - $4.74 Million	-95,100 Reduced 16.21%	491,615 $17.4 Million
Q4 2019 Feb 12, 2020	SELL	$24.84 - $45.46 $1.23 Million - $2.25 Million	-49,500 Reduced 7.78%	586,715 $26.7 Million
Q1 2019 May 14, 2019	SELL	$14.02 - $16.74 $218,712 - $261,143	-15,600 Reduced 2.39%	636,215 $10.3 Million
Q4 2018 Feb 12, 2019	SELL	$10.95 - $15.44 $747,720 - $1.05 Million	-68,285 Reduced 9.48%	651,815 $9.57 Million
Q3 2018 Nov 13, 2018	SELL	$12.21 - $16.61 $761,904 - $1.04 Million	-62,400 Reduced 7.97%	720,100 $11.3 Million
Q2 2018 Aug 14, 2018	SELL	$11.13 - $21.86 $458,556 - $900,632	-41,200 Reduced 5.0%	782,500 $11.6 Million
Q3 2017 Nov 13, 2017	BUY	$6.48 - $8.73 $5.34 Million - $7.19 Million	823,700	823,700 $6.57 Million

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.05 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $844M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account